Skip to content

Clinical trials

Terminated Carcinoma, Merkel Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Status: Terminated Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20141
20152
20161
20172
20182
20196
20206
20215
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fate Therapeutics3
Fred Hutchinson Cancer Center3
ImmunityBio, Inc.2
Pfizer2
Ariceum Therapeutics GmbH1
Craig L Slingluff, Jr1
Dana-Farber Cancer Institute1
Exicure, Inc.1
Genocea Biosciences, Inc.1
Incyte Biosciences International Sàrl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell29
Melanoma15
Carcinoma, Renal Cell12
Carcinoma, Non-Small-Cell Lung11
Small Cell Lung Carcinoma10
Carcinoma, Transitional Cell9
Carcinoma, Hepatocellular8
Neoplasm Metastasis8
Stomach Neoplasms8
Triple Negative Breast Neoplasms8

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.